Education of Caregivers of Alzheimer's Patients
The Effect of Education Given to Caregivers of Alzheimer's Patients Registered With Home Health Services on Their Knowledge and Attitudes Towards Alzheimer's Disease: Randomized Controlled Study
1 other identifier
interventional
60
1 country
1
Brief Summary
Purpose of the Research: This study will be conducted to determine the effect of the education given to caregivers of Alzheimer's patients registered to home health services on their knowledge and attitudes towards Alzheimer's disease. Hypotheses of the Research H01: The education given to caregivers of Alzheimer's patients registered to home health services does not affect the caregivers' level of knowledge about Alzheimer's disease. H11: The education given to caregivers of Alzheimer's patients registered to home health services increases the caregivers' level of knowledge about Alzheimer's disease. H02: The education given to caregivers of Alzheimer's patients registered to home health services does not affect the caregivers' attitudes towards Alzheimer's disease. H12: The education given to caregivers of Alzheimer's patients registered to home health services positively affects the caregivers' attitudes towards Alzheimer's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2023
CompletedFirst Posted
Study publicly available on registry
December 27, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2024
CompletedDecember 27, 2023
December 1, 2023
5 months
December 13, 2023
December 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Alzheimer's Disease Knowledge Scale
The scale developed by Carpenter et al. (2009) was adapted to Turkish by Yılmaz and Çolak (2020). The scale consists of 30 items and evaluates people's level of knowledge about Alzheimer's disease. Scale items can be answered as true or false, and participants receive one point for each item they answer correctly. The scores that can be obtained from the scale vary between 0 and 30. An increase in the score obtained from the scale indicates that the level of knowledge is high. While the difficulty index values of the scale items ranged between 0.24 and 0.75, the discrimination index was calculated above 0.10. The test-retest reliability calculated to evaluate the reliability of the scale was found to be 0.81, and the Kuder-Richardson 20 coefficient was found to be 0.74.
In the pre-test of the research, the "Alzheimer's Disease Knowledge Scale" will be administered to the caregivers by the researcher, and the "Alzheimer's Disease Knowledge Scale" will be administered again 1 month later.
Dementia Attitude Scale
The scale was developed by O'Connor and McFadden in 2010 and translated into Turkish by Çetinkaya et al. Adapted from (2020). The scale was used with university students and direct care workers. During the creation of the scale, the expression "Alzheimer's disease and related diseases" was used in the scale expressions due to the terminological confusion between Alzheimer's Disease and Dementia. The scale is a 7-point Likert type, from 1 (strongly disagree) to 7 (strongly agree). 6 items of the scale, which consists of a total of 20 items, are reverse scored (2,6,8,9,16,17). As the score obtained from the scale increases, supportive and accepting attitudes increase, while exclusionary attitudes decrease. Cronbach's alpha value of the scale was found to be 0.83.
In the pre-test of the research, the "Dementia Attitude Scale" will be administered to the caregivers by the researcher, and the "Dementia Attitude Scale" will be administered again 1 month later.
Study Arms (2)
Experimental
EXPERIMENTALWithin the scope of the research, caregivers will be given face-to-face training in 2 sessions, 15 days apart.
Control
NO INTERVENTIONThey will receive routine home health care follow-up.
Interventions
They will receive routine home health care follow-up.
Eligibility Criteria
You may qualify if:
- Those who are primarily responsible for the care of the patient diagnosed with Alzheimer's disease,
- Caring for a patient diagnosed with Alzheimer's disease for at least 6 months,
- Ages 18 and over,
- The one who is literate,
- Open to communication and collaboration,
- Caregivers who volunteer to participate in the study will be included in the study.
You may not qualify if:
- Cannot understand and speak Turkish,
- Those with mental and cognitive retardation and
- Caregivers who do not want to continue the research will be excluded from the research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ordu Universitylead
Study Sites (1)
Hacer GÖK UĞUR
Ordu, Cumhuriyet Campus, 52000, Turkey (Türkiye)
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Hacer GÖK Uğur, Asoss.Prof.
Ordu Univercity
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
December 13, 2023
First Posted
December 27, 2023
Study Start
January 1, 2024
Primary Completion
May 30, 2024
Study Completion
August 30, 2024
Last Updated
December 27, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share